+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostics Market Size, Share & Trends Analysis Report by Technology & Product (ISH, Digital Pathology and Workflow), by Application (Breast Cancer, Prostate Cancer), by End Use, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4751821
  • Report
  • February 2020
  • Region: Global
  • 240 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere, Inc.
  • Bio SB
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • MORE
The global tissue diagnostics market size is anticipated to reach USD 6.6 billion by 2027, growing at a CAGR of 5.9% during the forecast period. Accelerating demand for automated tissue diagnostic systems due to the lack of skilled pathologists has driven the market. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplement market growth.

The digitalization of tissue diagnostic techniques has resulted in the improvement of workflows and better patient care. Ongoing strategic models taken-up by key companies to enhance the efficiency of diagnostics also drives the market. For instance, in December 2019, Philips collaborated with Paige to provide clinical-grade artificial intelligence-based solutions to pathology laboratories. This enhanced the speed and accuracy of cancer diagnostics in laboratories.

Tissue diagnostic techniques, such as immunohistochemistry (IHC) or in situ hybridization, are used in companion diagnostics (CDx) to determine the quantity of a target analyte present in the sample. Introduction of CDx tests, such as the launch of the VENTANA HER2 Dual ISH CDx

Further key findings from the report suggest:
  • IHC tests are highly adopted as these tests are specific and helpful in identifying the variations between different types of cancer, resulting in the largest revenue share
  • A rise in the investments for the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment with the fastest CAGR.
  • Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth
  • A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of breast cancer
  • Prostate cancer is anticipated to register lucrative growth owing to the extensive ongoing research pertaining to early diagnosis and prevention of this disease
  • Hospitals dominated the market in terms of revenue share due to the high adoption of tissue diagnostics solutions. These solutions provide accurate results in minimal time than conventional testing procedures
  • North America accounted for the largest revenue share owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings
  • The requirement of better laboratory management systems, growing demand for novel patient care facilities, and favorable regulatory framework, boost the Asia Pacific market at a lucrative pace
  • Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market
  • Key vendors are engaged in novel product developments, partnership, and acquisition models to maintain their revenue share in the market.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere, Inc.
  • Bio SB
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • MORE
Chapter 1 Executive Summary
1.1 Market Overview
1.2 Market Segmentation & Scope
1.3 Competitive Insights

Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 internal database
2.1.3 Secondary sources:
2.1.4 Primary research:
2.1.5 Details of primary research
2.2 Information or Data Analysis
2.2.1 Data analysis models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity flow analysis (Model 1)
2.4.1.1 Approach 1: Commodity flow approach
2.4.2 Volume price analysis (Model 2)
2.4.2.1 Approach 2: Volume price analysis
2.5 List of Secondary Sources
2.6 List of Primary Sources
2.7 Objectives
2.7.1 Objective 1
2.7.2 Objective 2

Chapter 3 Tissue Diagnostics Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Worldwide increase in cancer prevalence
3.1.1.2 Advancements in imaging techniques and increasing affordability of diagnostics
3.1.1.3 Growth of personalized therapeutics and diagnostics
3.1.2 Market restraint analysis
3.1.2.1 The high costs associated with R&D and clinical trials
3.1.2.2 Presence of non-value based reimbursement policy
3.2 Penetration & Growth Prospect Mapping For Applications, 2019
3.3 Tissue Diagnostics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
3.5 Tissue Diagnostics Market : Technology Timeline
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 Merger & acquisition
3.6.2 Collaboration & partnership
3.6.3 Agreement

Chapter 4 Tissue Diagnostics Market: Technology & Product Estimates & Trend Analysis
4.1 Global Tissue Diagnostics Market: Technology Movement Analysis
4.2 Immunohistochemistry
4.2.1 Global immunohistochemistry for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.2 Instruments
4.2.2.1 Global immunohistochemistry instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.2.2 Slide staining systems
4.2.2.2.1 Global immunohistochemistry slide staining systems for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.2.3 Tissue microarrays
4.2.2.3.1 Global immunohistochemistry tissue microarrays for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.2.4 Tissue processing systems
4.2.2.4.1 Global immunohistochemistry tissue processing systems for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.2.5 Slide scanners
4.2.2.5.1 Global immunohistochemistry slide scanners for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.2.6 Other products
4.2.2.6.1 Global immunohistochemistry other products for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.3 Consumables
4.2.3.1 Global immunohistochemistry consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.3.2 Reagents
4.2.3.2.1 Global immunohistochemistry reagents for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.3.3 Antibodies
4.2.3.3.1 Global immunohistochemistry antibodies for tissue diagnostics market, 2016 - 2027 (USD Million)
4.2.3.4 Kits
4.2.3.4.1 Global immunohistochemistry kits for tissue diagnostics market, 2016 - 2027 (USD Million)
4.3 In-situ Hybridization
4.3.1 Global in-situ hybridization for tissue diagnostics market, 2016 - 2027 (USD Million)
4.3.2 Instruments
4.3.2.1 Global in-situ hybridization instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
4.3.3 Consumables
4.3.3.1 Global in-situ hybridization consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
4.3.4 Software
4.3.4.1 Global in-situ hybridization software for tissue diagnostics market, 2016 - 2027 (USD Million)
4.4 Primary & Special Staining
4.4.1 Global primary & special staining for tissue diagnostics market, 2016 - 2027 (USD Million)
4.5 Digital Pathology & Workflow
4.5.1 Global digital pathology & workflow for tissue diagnostics market, 2016 - 2027 (USD Million)
4.5.2 Whole slide imaging
4.5.2.1 Global digital pathology & workflow whole slide imaging for tissue diagnostics market, 2016 - 2027 (USD Million)
4.5.3 Image analysis informatics
4.5.3.1 Global digital pathology & workflow image analysis informatics for tissue diagnostics market, 2016 - 2027 (USD Million)
4.5.4 Information management system storage & communication
4.5.4.1 Global digital pathology & workflow information management system storage & communication for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6 Anatomic Pathology
4.6.1 Global anatomic pathology for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.2 Instruments
4.6.2.1 Global anatomic pathology instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.2.2 Microtomes & cryostat
4.6.2.2.1 Global anatomic pathology microtomes & cryostat for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.2.3 Tissue processors
4.6.2.3.1 Global anatomic pathology tissue processors for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.2.4 Automatic strainers
4.6.2.4.1 Global anatomic pathology automatic strainers for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.2.5 Other products
4.6.2.5.1 Global other anatomic pathology instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.3 Consumables
4.6.3.1 Global anatomic pathology consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.3.2 Reagents & antibodies
4.6.3.2.1 Global anatomic pathology reagents & antibodies for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.3.3 Kits & probes
4.6.3.3.1 Global anatomic pathology kits & probes for tissue diagnostics market, 2016 - 2027 (USD Million)
4.6.3.4 Others
4.6.3.4.1 Global other anatomic pathology consumables for tissue diagnostics market, 2016 - 2027 (USD Million)

Chapter 5 Tissue Diagnostics Market: Application Estimates & Trend Analysis
5.1 Global Tissue Diagnostics Market: Application Movement Analysis
5.2 Breast Cancer
5.2.1 Global tissue-based breast cancer diagnostics market, 2016 - 2027 (USD Million)
5.3 Non-small Cell Lung Cancer (NSCLC)
5.3.1 Global tissue-based NSCLC diagnostics market, 2016 - 2027 (USD Million)
5.4 Prostate Cancer
5.4.1 Global tissue-based prostate cancer diagnostics market, 2016 - 2027 (USD Million)
5.5 Gastric Cancer
5.5.1 Global tissue-based gastric cancer diagnostics market, 2016 - 2027 (USD Million)
5.6 Other Cancers
5.6.1 Global tissue-based other cancer diagnostics market, 2016 - 2027 (USD Million)

Chapter 6 Tissue Diagnostics Market: End-use Category Estimates & Trend Analysis
6.1 Global Tissue Diagnostics Market: End-use Category Movement Analysis
6.2 Hospitals
6.2.1 Global hospital-based tissue diagnostics market, 2016 - 2027 (USD Million)
6.3 Research Laboratories
6.3.1 Global research laboratories market, 2016 - 2027 (USD Million)
6.4 Pharmaceutical Organizations
6.4.1 Global pharmaceutical organizations market, 2016 - 2027 (USD Million)
6.5 Contract Research Organizations (CROS)
6.5.1 Global CROs-based tissue diagnostics market, 2016 - 2027 (USD Million)

Chapter 7 Tissue Diagnostics Market: Regional Estimates & Trend Analysis, by, Technology & Product, Application, & End-use
7.1 Tissue Diagnostics Market Share By Region, 2019 & 2027
7.2 North America
7.2.1 North America tissue diagnostics market, 2016 - 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.2.2.2 U.S. tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.2.2.3 U.S. tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.2.3.2 Canada tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.2.3.3 Canada tissue diagnostics market, by enduse, 2016 - 2027 (USD Million)
7.3 Europe
7.3.1 Europe tissue diagnostics market, 2016 - 2027 (USD Million)
7.3.2 Germany
7.3.2.1 Germany tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.3.2.2 Germany tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.3.2.3 Germany tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.3.3 France
7.3.3.1 France tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.3.3.2 France tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.3.3.3 France tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.3.4 Spain
7.3.4.1 Spain tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.3.4.2 Spain tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.3.4.3 Spain tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific tissue diagnostics market, 2016 - 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.4.2.2 Japan tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.4.2.3 Japan tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.4.3 China
7.4.3.1 China tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.4.3.2 China tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.4.3.3 China tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.4.4 India
7.4.4.1 India tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.4.4.2 India tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.4.4.3 India tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America tissue diagnostics market, 2016-2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.5.2.2 Brazil tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.5.2.3 Brazil tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.5.3.2 Mexico tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.5.3.3 Mexico tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa tissue diagnostics market, 2016 - 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
7.6.2.2 South Africa tissue diagnostics market, by application, 2016 - 2027 (USD Million)
7.6.2.3 South Africa tissue diagnostics market, by end use, 2016 - 2027 (USD Million)

Chapter 8 Competitive Landscape
8.1 Company Categorization
8.2 Recent Developments & Impact Analysis, by Key Market Participants
8.3 Public Companies
8.3.1 Company market position analysis
8.4 Private Companies
8.4.1 List of key emerging companies
8.5 Strategy Framework
8.6 Company Profiles
8.6.1 F. Hoffmann-La Roche Ltd.
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Abbott Laboratories
8.6.2.1 Company overview
8.6.2.1.1 Alere, Inc.
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic initiatives
8.6.3 Siemens
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic initiatives
8.6.4 Danaher
8.6.4.1 Company overview
8.6.4.1.1 Beckman Coulter, Inc.
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic initiatives
8.6.5 bioMérieux SA
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic initiatives
8.6.6 QIAGEN
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic initiatives
8.6.7 Becton Dickinson & Company
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 Merck KGaA
8.6.8.1 Company overview
8.6.8.1.1 Bio Reliance
8.6.8.1.2 Sigma-Aldrich Co. LLC
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 Thermo Fisher Scientific, Inc.
8.6.9.1 Company overview
8.6.9.1.1 Life Technologies Corporation
8.6.9.1.2 Affymetrix, Inc.
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.10 Agilent Technologies, Inc.
8.6.10.1 Company overview
8.6.10.2 Financial performance
8.6.10.3 Product benchmarking
8.6.10.4 Strategic initiatives
8.6.11 GE Healthcare
8.6.11.1 Company overview
8.6.11.2 Financial performance
8.6.11.3 Product benchmarking
8.6.11.4 Strategic initiatives
8.6.12 BioGenex
8.6.12.1 Company overview
8.6.12.2 Financial performance
8.6.12.3 Product benchmarking
8.6.12.4 Strategic initiatives
8.6.13 Cell Signaling Technology, Inc.
8.6.13.1 Company overview
8.6.13.2 Financial performance
8.6.13.3 Product benchmarking
8.6.13.4 Strategic initiatives
8.6.14 Bio SB
8.6.14.1 Company overview
8.6.14.2 Financial performance
8.6.14.3 Product benchmarking
8.6.14.4 Strategic initiatives
8.6.15 DiaGenic ASA
8.6.15.1 Company overview
8.6.15.2 Financial performance
8.6.15.3 Product benchmarking
8.6.15.4 Strategic initiatives
8.6.16 Sakura Finetek Japan Co. Ltd.
8.6.16.1 Company overview
8.6.16.2 Financial performance
8.6.16.3 Product benchmarking
8.6.16.4 Strategic initiatives
8.6.17 Abcam plc
8.6.17.1 Company overview
8.6.17.2 Financial performance
8.6.17.3 Product benchmarking
8.6.17.4 Strategic initiatives
8.6.18 Enzo Life Sciences, Inc.
8.6.18.1 Company overview
8.6.18.2 Financial performance
8.6.18.3 Product benchmarking
8.6.18.4 Strategic initiatives
8.6.19 Master Diagnóstica
8.6.19.1 Company overview
8.6.19.2 Financial performance
8.6.19.3 Product benchmarking
8.6.19.4 Strategic initiatives
8.6.20 TissueGnostics GmbH
8.6.20.1 Company overview
8.6.20.2 Financial performance
8.6.20.3 Product benchmarking
8.6.20.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Alere, Inc.
  • Siemens
  • Danaher
  • Beckman Coulter, Inc.
  • bioMérieux SA
  • QIAGEN
  • Becton Dickinson & Company
  • Merck KGaA
  • Bio Reliance
  • Sigma-Aldrich Co. LLC
  • Thermo Fisher Scientific, Inc.
  • Life Technologies Corporation
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • GE Healthcare
  • BioGenex
  • Cell Signaling Technology, Inc.
  • Bio SB
  • DiaGenic ASA
  • Sakura Finetek Japan Co. Ltd.
  • Abcam plc
  • Enzo Life Sciences, Inc.
  • Master Diagnóstica
  • TissueGnostics GmbH
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll